Viewing Study NCT02655458


Ignite Creation Date: 2025-12-25 @ 12:26 AM
Ignite Modification Date: 2026-02-21 @ 1:22 AM
Study NCT ID: NCT02655458
Status: COMPLETED
Last Update Posted: 2017-08-18
First Post: 2016-01-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Elotuzumab in Autologous Stem Cell Transplantation (ASCT) and Lenalidomide Maintenance for Multiple Myeloma
Sponsor: Hearn Jay Cho
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module